Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants

American Journal of Psychiatry

Volumn 163, Issue 2, 2006, Pages 313-315

  Altshulesr, Lori L ^a   Suppes, Trisha ^b   Black, David O ^b   Nolen, Willem A ^b   Leverich, Gabriele ^b   Keck Jr , Paul E ^b   Frye, Mark A ^b   Kupka, Ralph ^b   McElroy, Susan L ^b   Grunze, Heinz ^b   Kitchen, Christina M R ^b   Post, Robert ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; PLACEBO; SERTRALINE; VALPROIC ACID; VENLAFAXINE; ANTICONVULSIVE AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; BIPOLAR MANIA; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYCLOTHYMIA; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE REGIMEN; FEMALE; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RAPID CYCLING BIPOLAR DISORDER; RATING SCALE; SWITCH RATE; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE; AMBULATORY CARE; BIPOLAR DISORDER; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; RECURRENT DISEASE;

ADULT; AMBULATORY CARE; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM; MALE; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE;

EID: 33645007140     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.163.2.313     Document Type: Article

References (17)

1. Judd LL, Schettler PJ, Akiskal HS, Maser J, Coryell W, Solomon D, Endicott J, Keller M: Long-term symptomatic status of bipolar I vs bipolar II disorders. Int J Neuropsychopharmacol 2003; 6:127-137
2. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM: Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004; 161:1537-1547
3. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff K, Nolen WA, Grunze H, Martinez MI, Post RM: Antidepressant augmentation in bipolar depression: a higher ratio of full switches to subthreshold hypomanias on venlafaxine than sertraline or bupropion in acute and continuation trials. Am J Psychiatry 2006; 163:232-239
4. Joffe RT, MacQueen GM, Marriott M, Robb J, Begin H, Young LT: Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant. Acta Psychiatr Scand 2002; 105:427-430
5. Serretti A, Artioli P, Zanardi R, Rossini D: Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27:751-757
6. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M: Antidepressant- induced mania in bipolar patients: identification of risk factors. J Clin Psychiatry 2001; 62:249-255
7. Post RM, Altshuler LL, Frye MA, Suppes T, Rush AJ, Keck PE Jr, McElroy SL, Denicoff KD, Leverich GS, Kupka R, Nolen WA: Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disord 2001; 3:259-265
8. Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE Jr, McElroy SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J: The Stanley Foundation Bipolar Network, I: rationale and methods. Br J Psychiatry Suppl 2001; 41:S169-S176
9. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM: The Stanley Foundation Bipolar Treatment Outcome Network, II: demographics and illness characteristics of the first 261 patients. J Affect Disord 2001; 67:45-59
10. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C: The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986; 18:65-87
11. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73:159-171
12. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
13. Peet M: Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164:549-550
14. Kupfer DJ, Chengappa KN, Gelenberg AJ, Hirschfeld RM, Goldberg JF, Sachs GS, Grochocinski VJ, Houck PR, Kolar AB: Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry 2001; 62:985-990
15. Amsterdam JD, Shults J, Brunswick DJ, Hundert M: Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate. Bipolar Disord 2004; 6:75-81
16. Simpson SG, DePaulo JR: Fluoxetine treatment of bipolar II depression. J Clin Psychopharmacol 1991; 11:52-54
17. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka R, Nolen WA, Grunze H, Martinez M, Post RM: The Range of Hypo/Manic Severities on Antidepressants: A Randomized, Double Blind Comparison of Bupropion, Sertraline, and Venlafaxine Using Daily NIMH-LCM Ratings. Acta Psychiatr Scand Suppl 2004; 39